SEC EDGAR · Company announcement
TDG: Leadership change
Filed 8-K for an event or period dated 2026-07-22. Leadership change.
Follow TDG- Became public
- Jul 24, 2026, 7:15 AM EDT
- Event / period date
- Jul 22, 2026
- Collected
- Nov 9, 2026, 3:47 PM EST
Why this is connected
This filing identifies TransDigm Group INC as the issuer of the security. The company's SEC identifier connects it to TDG.
Source evidence
Read the source excerpt or record
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 22, 2026, the Board of Directors (the “Board”) of TransDigm Group Incorporated (the “Company” or “TransDigm”) appointed Irina Krasik to the Company’s Board of Directors, effective immediately. Ms. Krasik has been with Stellex Capital Management since 2021 and serves as a Managing Director. Prior to joining Stellex Capital Management, she was a Principal at Bregal Investments and previously spent more than eight years at The Wicks Group in various investment roles. Earlier in her career, Ms. Krasik held positions at The Carlyle Group and Merrill Lynch. She currently serves on the boards of directors of several privately held companies and brings to the Board extensive experience in mergers and acquisitions, investing, corporate strategy and governance. Ms. Krasik holds an M.B.A. from Harvard Business School and a B.S. in Finance from Rutgers University. Ms. Krasik has not been appointed to any committees of the Board. There are no arrangements or understandings between Ms. Krasik and any other person pursuant to which she was selected as a director, and there are no related person transactions between Ms. Krasik and the Company that would be reportable under Item 404(a) of Regulation S-K. Ms. Krasik will receive compensation for her services on the Company’s Board of Directors in accordance with the Company’s standard compensation arrangements for non-employee directors as set forth in the Company’s proxy statement for its 2026 annual meeting. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
Price change after we could observe it
+1.59% TDG
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in TDG
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
Committee overlap: Science - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 28, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 7 days before earnings - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 22, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 21, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 13, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 8, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 7, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.